1. Khan, G.B., M. Qasim, A. Rasul, U.A. Ashfaq and A.M. Alnuqaydan, 2023. Identification of lignan compounds as new 6-phosphogluconate dehydrogenase inhibitors for lung cancer. Metabolites, Vol. 13. 10.3390/metabo13010034.
   CrossRef  |  Direct Link  |  
2. Umar, A., S. Liaquat, I. Fatima, A. Rehman and D. Rasool et al., 2022. Vaccinomics to design a multiepitope vaccine against legionella pneumophila. BioMed Res. Int., Vol. 2022. 10.1155/2022/4975721.
   CrossRef  |  Direct Link  |  
3. Tabassum, S., H.R. Khalid, Waqar ul Haq, S. Aslam and A. Alshammari et al., 2022. Implementation of system pharmacology and molecular docking approaches to explore active compounds and mechanism of ocimum sanctum against tuberculosis. Processes, Vol. 10. 10.3390/pr10020298.
   CrossRef  |  Direct Link  |  
4. Saddique, F.A., M. Ahmad, U.A. Ashfaq, M. Muddassar, S. Sultan and M.E.A. Zaki, 2022. Identification of cyclic sulfonamides with an N-arylacetamide group as α-glucosidase and α-amylase inhibitors: Biological evaluation and molecular modeling. Pharmaceuticals, Vol. 15. 10.3390/ph15010106.
   CrossRef  |  Direct Link  |  
5. Rashid, F., M. Ahmad, U.A. Ashfaq, A.A. Al-Mutairi and S.A. Al-Hussain, 2022. Design, synthesis and pharmacological evaluation of 2-(3-benzoyi-4-hydroxy-1,1-dioxido-2H-benzo[e][1,2]thiazin-2-yI)-N-(2-Bromophenyl) acetamide as antidiabetic agent. Drug Des. Dev. Ther., 16: 4043-4060.
   CrossRef  |  Direct Link  |  
6. Rashid, F., A. Javaid, Mahmood-ur-Rahman, U.A. Ashfaq and M. Sufyan et al., 2022. Integrating pharmacological and computational approaches for the phytochemical analysis of Syzygium cumini and its anti-diabetic potential. Molecules, Vol. 27. 10.3390/molecules27175734.
   CrossRef  |  Direct Link  |  
7. Noor, F., M. Tahir ul Qamar, U.A. Ashfaq, A. Albutti, A.S.S. Alwashmi and M.A. Aljasir, 2022. Network pharmacology approach for medicinal plants: Review and assessment. Pharmaceuticals, Vol. 15. 10.3390/ph15050572.
   CrossRef  |  Direct Link  |  
8. Noor, F., A. Rehman, U.A. Ashfaq, M.H. Saleem and M.K. Okla et al., 2022. Integrating network pharmacology and molecular docking approaches to decipher the multi-target pharmacological mechanism of Abrus precatorius L. acting on diabetes. Pharmaceuticals, Vol. 15. 10.3390/ph15040414.
   CrossRef  |  Direct Link  |  
9. Munir, S., M. Khurshid, M. Ahmad, U.A. Ashfaq and M.E.A. Zaki, 2022. Exploring the antimicrobial and pharmacological potential of NF22 as a potent inhibitor of E. coli DNA gyrase: An in vitro and in silico study. Pharmaceutics, Vol. 14. 10.3390/pharmaceutics14122768.
   CrossRef  |  Direct Link  |  
10. Khan, I.A., F.A. Saddique, S. Aslam, U.A. Ashfaq, M. Ahmad, S.A. Al-Hussain and M.E.A. Zaki, 2022. Synthesis of novel N-methylmorpholine-substituted benzimidazolium salts as potential α-glucosidase inhibitors. Molecules, Vol. 27. 10.3390/molecules27186012.
    CrossRef  |  Direct Link  |  
11. Khalid, H.R., M. Aamir, S. Tabassum, Y.S. Alghamdi, A. Alzamami and U.A. Ashfaq, 2022. Integrated system pharmacology approaches to elucidate multi-target mechanism of Solanum surattense against hepatocellular carcinoma. Molecules, Vol. 27. 10.3390/molecules27196220.
    CrossRef  |  Direct Link  |  
12. Khalid, H., S. Khalid, M. Sufyan and U.A. Ashfaq, 2022. In-silico elucidation reveals potential phytochemicals against angiotensin-converting enzyme 2 (ACE-2) receptor to fight coronavirus disease 2019 (COVID-19). Z. Naturforsch. C, 77: 473-482.
    CrossRef  |  Direct Link  |  
13. Khalid, H. and U.A. Ashfaq, 2022. Molecular docking and pharmacoinformatics studies reveal potential phytochemicals against HCV NS5B polymerase. Comb. Chem. High Throughput Screening, 25: 335-346.
    CrossRef  |  Direct Link  |  
14. Kanwal, A., F. Azeem, H. Nadeem, U.A. Ashfaq and R.M. Aadil et al., 2022. Molecular mechanisms of Cassia fistula against epithelial ovarian cancer using network pharmacology and molecular docking approaches. Pharmaceutics, Vol. 14. 10.3390/pharmaceutics14091970.
    CrossRef  |  Direct Link  |  
15. Javaid, A., A. Ijaz, U.A. Ashfaq, M. Arshad, S. Irshad and S. Saif, 2022. An overview of chikungunya virus molecular biology, epidemiology, pathogenesis, treatment and prevention strategies. Future Virol., 17: 593-606.
    CrossRef  |  Direct Link  |  
16. Alshammari, A., M. Alharbi, A. Alghamdi, S.A. Alharbi and U.A. Ashfaq et al., 2022. Computer-aided multi-epitope vaccine design against Enterobacter xiangfangensis. Int. J. Environ. Res. Public Health, Vol. 19. 10.3390/ijerph19137723.
    CrossRef  |  Direct Link  |  
17. Alshammari, A., A.F. Alasmari, M. Alharbi, N. Ali and Z.T. Muhseen et al., 2022. Novel chimeric vaccine candidate development against Leptotrichia buccalis. Int. J. Environ. Res. Public Health, Vol. 19. 10.3390/ijerph191710742.
    CrossRef  |  Direct Link  |  
18. Alamri, M.A., M.U. Mirza, M.M. Adeel, U.A. Ashfaq and M. Tahir ul Qamar et al., 2022. Structural elucidation of rift valley fever virus l protein towards the discovery of its potential inhibitors. Pharmaceuticals, Vol. 15. 10.3390/ph15060659.
    CrossRef  |  Direct Link  |  
19. Umar, A., A. Haque, Y.S. Alghamdi, M.M. Mashraqi and A. Rehman et al., 2021. Development of a candidate multi-epitope subunit vaccine against Klebsiella aerogenes: Subtractive proteomics and immuno-informatics approach. Vaccines, Vol. 9. 10.3390/vaccines9111373.
    CrossRef  |  Direct Link  |  
20. Tariq, M.H., R. Bhatti, N.F. Ali, U.A. Ashfaq, F. Shahid, A. Almatroudi and M. Khurshid, 2021. Rational design of chimeric multiepitope based vaccine (MEBV) against human T-cell lymphotropic virus type 1: An integrated vaccine informatics and molecular docking based approach. PLoS ONE, Vol. 16. 10.1371/journal.pone.0258443.
    CrossRef  |  Direct Link  |  
21. Sufyan, M., F. Shahid, F. Irshad, A. Javaid, M. Qasim and U.A. Ashfaq, 2021. Implementation of vaccinomics and in-silico approaches to construct multimeric based vaccine against ovarian cancer. Int. J. Pept. Res. Ther., 27: 2845-2859.
    CrossRef  |  Direct Link  |  
22. Khalid, H., S. Shahid, S. Tariq, B. Ijaz, U.A. Ashfaq and M. Ahmad, 2021. Discovery of Novel HCV NS5B polymerase inhibitor, 2-(3,4-dimethyl-5,5-dioxidobenzo[e]pyrazolo[4,3-c][1,2]thiazin-2(4H)-yl)-N-(2-fluorobenzyl)acetamide via molecular docking and experimental approach. Clin. Exp. Pharmacol. Physiol., 48: 1653-1661.
    CrossRef  |  Direct Link  |  
23. Aslam, S., S. Ahmad, F. Noor, U.A. Ashfaq and F. Shahid et al., 2021. Designing a multi-epitope vaccine against Chlamydia trachomatis by employing integrated core proteomics, immuno-informatics and in silico approaches. Biology, Vol. 10. 10.3390/biology10100997.
    CrossRef  |  Direct Link  |  
24. Abdur Rehman, X. Wang, S. Ahmad, F. Shahid and S. Aslam et al., 2021. In silico core proteomics and molecular docking approaches for the identification of novel inhibitors against Streptococcus pyogenes. Int. J. Environ. Res. Public Health, Vol. 18. 10.3390/ijerph182111355.
    CrossRef  |  Direct Link  |